Pancreatic Cancer Research

ResearcherSpanish National Cancer Research CentreActive in the last 2 years

Paola Martinelli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-1643-8731; OpenAlex author ID A5038901717. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
64
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 11

  1. GATA4 loss promotes mutant Kras -driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions Co-author DOI 10.64898/2026.05.22.724502↗
  2. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2021-325564↗
  3. GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2021-325803↗
  4. A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer. Last author DOI 10.1136/gutjnl-2020-321397↗
  5. ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity. Co-author DOI 10.1038/s41467-020-16395-2↗
  6. Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions. Co-author DOI 10.3390/cancers12082005↗
  7. Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance. Co-author DOI 10.1038/s41388-019-0803-9↗
  8. The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures. First author DOI 10.1155/2019/1378639↗
  9. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2015-311256↗
  10. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Co-author DOI 10.1053/j.gastro.2014.08.002↗
  11. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. Co-author DOI 10.1371/journal.pone.0022129↗

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Francisco X. Real · 6 shared papers, 2011–2026 · strength 0.61
  2. Bruno Sáinz · 6 shared papers, 2014–2023 · strength 0.50
  3. Patrick Christian Hermann · 5 shared papers, 2014–2023 · strength 0.45
  4. Sonia Alcalá · 4 shared papers, 2019–2023 · strength 0.41
  5. Mónica P. de Andrés · 2 shared papers, 2023–2026 · strength 0.37
  6. Juan Iovanna · 2 shared papers, 2017–2026 · strength 0.30
  7. Sandra Valle · 3 shared papers, 2019–2023 · strength 0.29
  8. Alfredo Carrato · 3 shared papers, 2019–2023 · strength 0.29
  9. Julie Earl · 3 shared papers, 2019–2023 · strength 0.29
  10. Christopher Heeschen · 3 shared papers, 2014–2023 · strength 0.28
  11. Francesc Madriles · 2 shared papers, 2014–2026 · strength 0.27
  12. Patricia Sancho · 3 shared papers, 2014–2023 · strength 0.25
  13. Scott W. Lowe · 1 shared paper, 2026 · strength 0.24
  14. Iréne Esposito · 1 shared paper, 2026 · strength 0.24
  15. Marta Alonso‐Nocelo · 2 shared papers, 2019–2023 · strength 0.20
  16. Paula Ghaneh · 2 shared papers, 2017–2023 · strength 0.19
  17. Núria Malats · 2 shared papers, 2017–2023 · strength 0.19
  18. John P. Neoptolemos · 2 shared papers, 2017–2023 · strength 0.19
  19. William Greenhalf · 2 shared papers, 2017–2023 · strength 0.19
  20. Eithne Costello · 2 shared papers, 2017–2023 · strength 0.19
  21. Wilko Weichert · 1 shared paper, 2023 · strength 0.13
  22. Sladjana Zagorac · 1 shared paper, 2023 · strength 0.13
  23. Anna Melissa Schlitter · 1 shared paper, 2023 · strength 0.13
  24. Irene Felipe‐Abrio · 1 shared paper, 2023 · strength 0.13
  25. Thomas Knösel · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.